Harmony Biosciences Holdings Inc

{ "date": [ "202612", "202712", "202812", "202912", "203012" ], "revenue_estimate": [ 1013.67, 1146.3, 1281.17, 1540.92, 1222.9 ], "ebit_estimate": [ 259.1, 318.29, 429.23, 581.26, 490.35 ], "ebitda_estimate": [ 293.6, 359.72, 372.97, 371.15, 431.05 ], "net_income_estimate": [ 209.77, 265.17, 332.05, 443.9, 409.53 ], "per_share_eps_estimate": [ 3.43, 4.17, 4.96, 6.69, 6.07 ], "eps_nri_estimate": [ 3.69, 4.09, 5.1, 6.62, 5.68 ], "dividend_estimate": [ null, null, null, null, null ], "book_value_per_share_estimate": [ 18.92, 24.05, 29.25, 37.1, 43.82 ], "pretax_income_estimate": [ 263.39, 342.18, 410.05, 543.02, 504.17 ], "operating_cash_flow_per_share_estimate": [ 4.92, 5.84, 5.51, 6.2, 6.49 ], "roa_estimate": [ 17.5, 14.5, 11.1, 10.9, 10.5 ], "roe_estimate": [ 25.56, 19.58, 16.42, 12.8, 11.9 ], "gross_margin_estimate": [ 76.55, 75.43, 75.73, 77.5, 79.25 ], "operating_cash_flow_estimate": [ 288.98, 343.06, 323.86, 364.41, 381.46 ], "pettm_estimate": [ 10.74, 8.84, 7.44, 5.52, 6.07 ], "long_term_growth_rate_mean": 22.17, "long_term_revenue_growth_rate_mean": "13.76", "future_per_share_eps_estimate_growth": 22.21, "future_eps_nri_estimate_growth": 22.17, "future_revenue_estimate_growth": 13.76, "future_ebit_estimate_growth": 26.77, "future_ebitda_estimate_growth": 17.4, "future_dividend_estimate_growth": null, "future_net_income_estimate_growth": 27.75, "future_pretax_income_estimate_growth": 24.58, "future_book_value_per_share_estimate_growth": 24.96, "future_roa_estimate_growth": null, "future_roe_estimate_growth": -9.23, "future_gross_margin_estimate_growth": -0.71, "future_operating_cash_flow_per_share_estimate_growth": null }

{ "date": [ "202606", "202609", "202612", "202703", "202706", "202709", "202712" ], "revenue_estimate": [ 242.06, 269.54, 286.87, 256.23, 280.87, 306.07, 320.5 ], "ebit_estimate": [ 68.59, 77.23, 84.62, 62.19, 78.43, 74.9, 88.01 ], "ebitda_estimate": [ 67.75, 80.46, 98.9, null, null, null, null ], "net_income_estimate": [ 53.5, 59.64, 60.38, 46.69, 59.41, 56.99, 67.08 ], "per_share_eps_estimate": [ 0.88, 0.98, 1.06, 0.79, 0.97, 0.97, 1.14 ], "eps_nri_estimate": [ 0.93, 1.04, 1.14, 0.79, 0.97, 0.97, 1.14 ], "dividend_estimate": [ null, null, null, null, null, null, null ], "book_value_per_share_estimate": [ null, null, null, null, null, null, null ], "pretax_income_estimate": [ 69.46, 77.34, 78.31, 60.91, 77.21, 73.68, 86.88 ], "operating_cash_flow_per_share_estimate": [ 0.81, 1.08, 1.49, null, null, null, null ], "roa_estimate": [ null, null, null, null, null, null, null ], "roe_estimate": [ null, null, null, null, null, null, null ], "gross_margin_estimate": [ 78.25, 75.25, 73.9, 81.9, 77.7, 65.3, 71.3 ], "operating_cash_flow_estimate": [ 47.32, 63.18, 87.28, null, null, null, null ], "pettm_estimate": [ 9.97, 9.74, 9.76, 9.56, null, null, null ], "long_term_growth_rate_mean": 22.17, "long_term_revenue_growth_rate_mean": "13.76", "future_per_share_eps_estimate_growth": 22.21, "future_eps_nri_estimate_growth": 22.17, "future_revenue_estimate_growth": 13.76, "future_ebit_estimate_growth": 26.77, "future_ebitda_estimate_growth": 17.4, "future_dividend_estimate_growth": null, "future_net_income_estimate_growth": 27.75, "future_pretax_income_estimate_growth": 24.58, "future_book_value_per_share_estimate_growth": 24.96, "future_roa_estimate_growth": null, "future_roe_estimate_growth": -9.23, "future_gross_margin_estimate_growth": -0.71, "future_operating_cash_flow_per_share_estimate_growth": null }